https://doi.org/10.1038/ncb3255
C
Changliang Shan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
102
Papers
4.8K
Citations
37
h-index
64
i10-index
Changliang Shan is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & RNA modifications and cancer & Epigenetics and DNA Methylation. The author has an h-index of 37, co-authored 87 publications.
ORCID: 0000-0002-4906-1686Papers by this author
works6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1–AMPK signalling
2015 · Nature Cell Biology · 277 citations
APEX2‐based Proximity Labeling of Atox1 Identifies CRIP2 as a Nuclear Copper‐binding Protein that Regulates Autophagy Activation
2021 · Angewandte Chemie International Edition · 72 citations
https://doi.org/10.1002/anie.202108961
Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/GPX4 expression
2024 · Journal of Experimental & Clinical Cancer Research · 61 citations
https://doi.org/10.1186/s13046-024-03032-9
PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism
2022 · Acta Pharmaceutica Sinica B · 60 citations
https://doi.org/10.1016/j.apsb.2022.05.019
Ciclopirox activates PERK-dependent endoplasmic reticulum stressto drive cell death in colorectal cancer
2020 · Cell Death and Disease · 48 citations
https://doi.org/10.1038/s41419-020-02779-1
Cellular energy stress induces AMPK-mediated regulation of glioblastoma cell proliferation by PIKE-A phosphorylation
2019 · Cell Death and Disease · 34 citations
https://doi.org/10.1038/s41419-019-1452-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat